Shin Nippon Biomedical Laboratories, Ltd. (2395.T)
JPY 1537.0
(-1.22%)
JPY 1537.0
(-1.22%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 18.14 Billion JPY | 84.48% |
| 2022 | 9.83 Billion JPY | 58.78% |
| 2021 | 6.19 Billion JPY | -32.65% |
| 2020 | 9.19 Billion JPY | 3.08% |
| 2019 | 8.92 Billion JPY | 93.88% |
| 2018 | 4.6 Billion JPY | -37.87% |
| 2017 | 7.4 Billion JPY | -34.42% |
| 2016 | 11.29 Billion JPY | -5.88% |
| 2015 | 12 Billion JPY | 4.23% |
| 2014 | 11.51 Billion JPY | -14.01% |
| 2013 | 13.39 Billion JPY | -0.65% |
| 2012 | 13.48 Billion JPY | -11.23% |
| 2011 | 15.18 Billion JPY | -4.4% |
| 2010 | 15.88 Billion JPY | -6.14% |
| 2009 | 16.92 Billion JPY | 3.41% |
| 2008 | 16.36 Billion JPY | 42.18% |
| 2007 | 11.51 Billion JPY | 13.13% |
| 2006 | 10.17 Billion JPY | 56.22% |
| 2005 | 6.51 Billion JPY | -18.61% |
| 2004 | 8 Billion JPY | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | 23.99 Billion JPY | 32.2% |
| 2023 Q4 | 18.14 Billion JPY | -2.87% |
| 2023 Q2 | 14.23 Billion JPY | -10.8% |
| 2023 Q1 | 15.96 Billion JPY | 62.24% |
| 2023 Q3 | 18.68 Billion JPY | 31.23% |
| 2023 FY | 18.14 Billion JPY | 84.48% |
| 2022 Q3 | 11.86 Billion JPY | -11.12% |
| 2022 Q2 | 13.35 Billion JPY | 45.64% |
| 2022 Q1 | 9.16 Billion JPY | 48.0% |
| 2022 FY | 9.83 Billion JPY | 58.78% |
| 2022 Q4 | 9.83 Billion JPY | -17.12% |
| 2021 Q4 | 6.19 Billion JPY | -14.07% |
| 2021 Q2 | 7.67 Billion JPY | -11.46% |
| 2021 Q1 | 8.66 Billion JPY | -5.76% |
| 2021 FY | 6.19 Billion JPY | -32.65% |
| 2021 Q3 | 7.2 Billion JPY | -6.07% |
| 2020 Q3 | 10.2 Billion JPY | -3.12% |
| 2020 Q1 | 11.77 Billion JPY | 31.89% |
| 2020 Q2 | 10.53 Billion JPY | -10.51% |
| 2020 FY | 9.19 Billion JPY | 3.08% |
| 2020 Q4 | 9.19 Billion JPY | -9.85% |
| 2019 Q3 | 8.66 Billion JPY | -5.25% |
| 2019 FY | 8.92 Billion JPY | 93.88% |
| 2019 Q1 | 4.08 Billion JPY | -11.31% |
| 2019 Q2 | 9.14 Billion JPY | 123.99% |
| 2019 Q4 | 8.92 Billion JPY | 3.0% |
| 2018 FY | 4.6 Billion JPY | -37.87% |
| 2018 Q3 | 5.1 Billion JPY | -10.34% |
| 2018 Q2 | 5.69 Billion JPY | -18.15% |
| 2018 Q1 | 6.95 Billion JPY | -6.1% |
| 2018 Q4 | 4.6 Billion JPY | -9.84% |
| 2017 Q4 | 7.4 Billion JPY | -12.42% |
| 2017 Q3 | 8.45 Billion JPY | -10.24% |
| 2017 Q2 | 9.42 Billion JPY | -7.22% |
| 2017 Q1 | 10.15 Billion JPY | -10.1% |
| 2017 FY | 7.4 Billion JPY | -34.42% |
| 2016 Q1 | 10.61 Billion JPY | -11.6% |
| 2016 Q2 | 13.62 Billion JPY | 28.39% |
| 2016 FY | 11.29 Billion JPY | -5.88% |
| 2016 Q4 | 11.29 Billion JPY | -8.61% |
| 2016 Q3 | 12.36 Billion JPY | -9.26% |
| 2015 Q1 | 10.3 Billion JPY | -10.54% |
| 2015 Q3 | 11.65 Billion JPY | -7.49% |
| 2015 Q2 | 12.59 Billion JPY | 22.27% |
| 2015 FY | 12 Billion JPY | 4.23% |
| 2015 Q4 | 12 Billion JPY | 3.0% |
| 2014 Q3 | 12.26 Billion JPY | -5.72% |
| 2014 FY | 11.51 Billion JPY | -14.01% |
| 2014 Q4 | 11.51 Billion JPY | -6.14% |
| 2014 Q1 | 11.99 Billion JPY | -10.48% |
| 2014 Q2 | 13.01 Billion JPY | 8.55% |
| 2013 Q3 | 13.99 Billion JPY | -7.82% |
| 2013 Q2 | 15.18 Billion JPY | 26.14% |
| 2013 Q1 | 12.03 Billion JPY | -10.71% |
| 2013 FY | 13.39 Billion JPY | -0.65% |
| 2013 Q4 | 13.39 Billion JPY | -4.32% |
| 2012 Q1 | 13.75 Billion JPY | -9.45% |
| 2012 Q4 | 13.48 Billion JPY | -8.1% |
| 2012 Q3 | 14.66 Billion JPY | -9.62% |
| 2012 Q2 | 16.23 Billion JPY | 18.02% |
| 2012 FY | 13.48 Billion JPY | -11.23% |
| 2011 Q4 | 15.18 Billion JPY | -5.03% |
| 2011 Q3 | 15.99 Billion JPY | -4.11% |
| 2011 Q2 | 16.67 Billion JPY | 11.72% |
| 2011 Q1 | 14.92 Billion JPY | -6.04% |
| 2011 FY | 15.18 Billion JPY | -4.4% |
| 2010 FY | 15.88 Billion JPY | -6.14% |
| 2010 Q1 | 15.74 Billion JPY | -6.97% |
| 2010 Q2 | 17.88 Billion JPY | 13.59% |
| 2010 Q3 | 17.03 Billion JPY | -4.73% |
| 2010 Q4 | 15.88 Billion JPY | -6.77% |
| 2009 Q4 | 16.92 Billion JPY | -6.71% |
| 2009 FY | 16.92 Billion JPY | 3.41% |
| 2009 Q3 | 18.14 Billion JPY | 13.53% |
| 2009 Q2 | 15.97 Billion JPY | 0.0% |
| 2008 FY | 16.36 Billion JPY | 42.18% |
| 2008 Q4 | 16.36 Billion JPY | 9.85% |
| 2008 Q3 | 14.89 Billion JPY | 0.0% |
| 2007 FY | 11.51 Billion JPY | 13.13% |
| 2006 FY | 10.17 Billion JPY | 56.22% |
| 2005 FY | 6.51 Billion JPY | -18.61% |
| 2004 FY | 8 Billion JPY | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| DNA Chip Research Inc. | - JPY | -Infinity% |
| Cosmo Bio Company,Limited | - JPY | -Infinity% |
| H.U. Group Holdings, Inc. | 60.1 Billion JPY | 69.804% |
| FALCO HOLDINGS Co., Ltd. | 148 Million JPY | -12162.078% |
| BML, Inc. | 3.73 Billion JPY | -386.277% |
| Human Metabolome Technologies, Inc. | 11.34 Million JPY | -159877.75% |
| Precision System Science Co., Ltd. | 289.67 Million JPY | -6164.953% |